Equity Research, Broker Reports, and media content on ABIOMED, Inc.

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ABIOMED, Inc.
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard


Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on ABIOMED, Inc.. We currently have 0 research reports from 0 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 0.00/0.00
  • Daily Volume: N/A
  • Daily Liquidity: 0.0%
  • # Shares: 0m
  • Market Cap: 0m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
01Nov18 11:00 GNW Abiomed Announces Q2 FY 2019 Record Revenue of $182 Million, up 37% Over Prior Year
26Jul18 12:00 GNW Abiomed Announces Q1 FY 2019 Record Revenue of $180 Million, Up 36% Over Prior Year
03May18 12:00 GNW Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year
05Apr18 06:46 GNW Abiomed Announces European Approval (CE Marking) for Impella 5.5(TM) and First Patient Treated at University Heart Center Hamburg
30Mar18 14:18 GNW Abiomed to Appoint New Chief Financial Officer Todd A. Trapp
01Feb18 12:00 GNW Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year
08Jan18 12:00 GNW Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154 Million, Up 34% Over Prior Year
  • Frequency of research reports


  • Research reports on

    ABIOMED, Inc.

  • Providers covering

    ABIOMED, Inc.